Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Oct 7 2021

Hepatitis C Drugs

  • Snapshot
    • A 54-year-old man presents to his primary care physician with fatigue and issues with sleep. His symptoms are associated with nausea and abdominal discomfort. A few days ago, he noted dark urine but denies any dysuria. He said that in the past he experienced severe right upper quadrant pain and jaundice approximately 8 years ago, requiring treatment which he does not remember the specifics. Social history is remarkable for intravenous drug use and had required a transfusion over a decade ago. Laboratory testing is remarkable for slightly elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level. He has a reactive HCV antibody and positive HCV RNA test. He is started on sofosbuvir-ledipasvir for chronic HCV infection.
  • Introduction
    • Note that none of these medications are used as monotherapy
      • Hepatitis C Drugs
      • Medications
      • Comments
      • Ledipasvir
      • Mechanism of action
        • hepatitis C virus (HCV)
          • NS5A protein inhibitorNS5A is an HCV viral phosphoprotein that is necessary for viral replication
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • headache
        • weakness
        • fatigue
      • Ribavirin
      • Mechanism of action
        • inosine monophosphate dehydrogenase competitive inhibitor
          • impairs viral DNA and RNA replication
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • hemolytic anemia
        • severe teratogen
      • Simeprevir
      • Mechanism of action
        • HCV protease (NS3/4A) inhibitor
          • NS3/4A is also essential for viral replication
          • this is a specifically targeted antiviral therapy for HCV
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • photosensitivity reactions
        • rash
      • Sofosbuvir
      • Mechanism of action
        • inhibits HCV RNA-dependent RNA polymerase (NS5B), which is also essential for viral replication
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • headache
        • fatigue
        • nausea
    • Mechanism of action
      • inosine monophosphate dehydrogenase competitive inhibitor
        • impairs viral DNA and RNA replication
    • Clinical use
      • HCV chronic infection
    • Adverse effects
      • hemolytic anemia
      • severe teratogen
    • Mechanism of action
      • HCV protease (NS3/4A) inhibitor
        • NS3/4A is also essential for viral replication
        • this is a specifically targeted antiviral therapy for HCV
    • Clinical use
      • HCV chronic infection
    • Adverse effects
      • photosensitivity reactions
      • rash
    • Mechanism of action
      • inhibits HCV RNA-dependent RNA polymerase (NS5B), which is also essential for viral replication
    • Clinical use
      • HCV chronic infection
    • Adverse effects
      • headache
      • fatigue
      • nausea
Card
1 of 0
Private Note